DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
265	脂肪萎縮症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00135460 (ClinicalTrials.gov)	June 2003	25/8/2005	Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparing Regimen in HIV Infected Patients	Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparing Regimen in Patients With HIV. Influence on Morphological and Metabolic Disorders. A Randomized, Open-Label Multicenter Trial.	HIV-Associated Lipodystrophy Syndrome	Drug: nucleoside analogue sparing HAART regimen	Danish HIV Research Group	Rigshospitalet, Denmark;Hvidovre University Hospital;Odense University Hospital;Aarhus University Hospital;Aalborg Universitetshospital;Abbott	Active, not recruiting	18 Years	N/A	Both	100	Phase 4	Denmark

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT00135460
(ClinicalTrials.gov)

June 2003

25/8/2005

Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparing Regimen in HIV Infected Patients

Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparing Regimen in Patients With HIV. Influence on Morphological and Metabolic Disorders. A Randomized, Open-Label Multicenter Trial.

HIV-Associated Lipodystrophy Syndrome

Drug: nucleoside analogue sparing HAART regimen

Danish HIV Research Group

Rigshospitalet, Denmark;Hvidovre University Hospital;Odense University Hospital;Aarhus University Hospital;Aalborg Universitetshospital;Abbott

Active, not recruiting

18 Years

N/A

Both

100

Phase 4

Denmark